Hypoxia-inducible factor1a in multistage carcinogenesis
多阶段癌变中的缺氧诱导因子1a
基本信息
- 批准号:6828120
- 负责人:
- 金额:$ 24.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-04-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (PROVIDED BY APPLICANT):Hypoxia inducible factor 1-alpha (HIF-1alpha)
is a component of the transcription factor HIF-1. Cell culture studies and
mouse gene knockouts demonstrate HIF-1alpha transactivation of genes controlling
angiogenesis, cellular metabolism, invasion and apoptosis. In addition to
hypoxia. HIF-1alpha protein expression is regulated by growth factor signaling and
survival pathways, and viral oncogenes. HIF-1alpha expression is induced in cancers
and high-grade premalignant lesions. However. HIF-1alpha function in each stage of
epithelial carcinogenesis or metastasis is unknown. We created transgenic mice
expressing either wild type or a constitutively active mutant HIF-1alpha lacking
the "oxygen-dependent degradation domain' about in basal squamous epithelium
(K14-HIF-1alpha and K14-HIF-1alpha delta ODD transgenic mice). We have engineered
Cre-loxP mediated HIF-1a deletion in basal squamous epithelium without a
discernable phenotype. Now we test whether HIF-1alpha plays a fundamental role in
multistage epithelial carcinogenesis with these Specific Aims
1. Determine the stage-specific effect of gain or loss of HIF-1alpha function on
Ha-ras initiated epidermal carcinogenesis. 1.1. Test whether gain of HIF- 1alpha
function promotes two-stage epidermal chemical carcinogenesis induced by
dimethylbenzanthracene and tetraphorbolmyristate acetate in Kl4-HIF-1alpha and
Kl4-HIF-laz\ODD transgenic mice. 1.2. Test necessity of HIF-1alpha in two-stage
chemical carcinogenesis in mice with Cre-loxP mediated epidermal HIF-1alpha
deletion. 2.0. Determine biology of gain of HIF-1alpha function on multistage
carcinogenesis in skin and cervix induced by the HPV16 early transforming
region. 2.1. Test alteration of each stage of HPV16-induced epidermal
carcinogenesis by gain of HIF-1alpha function in KI4-HPV16:HIF-1alpha or HIF-1alpha
delta ODD double transgenic mice. 2.2. Test cooperation between HIF-1alpha gain of
function and estrogen in HPV16 induced cervical carcinogenesis in mice
transgenic for the HPV16 and HIF-1alpha or HIF-1alpha delta ODD. 3.0. Test biology
of HPV16 E6-HIF-1alpha coexpression, and determine p53 dependent or independent
functions of E6 in conjunction with HIF-1alpha. 3.1. Create Kl4-E6HIF-1alpha or
K14-E6:HlF-1alpha delta ODD double transgenic mice and determine alterations in the
biology of skin and cervical carcinogenesis. 3.2. Create Kl4-E6 HIF-1alpha or
K14-E6:HIF-1alpha delta ODD double transgenic mice and determine alterations in the
biology of skin and cervical carcinogenesis. Our possession of all relevant
animal models, positions us to determine the precise role of HIF-1alpha in
carcinogenesis mediated by either activated oncogenes or inactivation of tumor
suppressor genes.
描述(申请人提供):缺氧诱导因子1-α(HIF-1 α)
是转录因子HIF-1的组成部分。细胞培养研究和
小鼠基因敲除证实HIF-1 α反式激活基因控制
血管生成、细胞代谢、侵袭和凋亡。除了
缺氧HIF-1 α蛋白表达受生长因子信号传导调节,
生存途径和病毒致癌基因。HIF-1 α在癌症中被诱导表达
和高级别癌前病变然而. HIF-1 α在乳腺癌各阶段的作用
上皮癌发生或转移尚不清楚。我们创造了转基因小鼠
表达野生型或缺乏组成型活性突变HIF-1 α,
基底鳞状上皮中存在“氧依赖性降解结构域
(K14-HIF-1 α和K14-HIF-1 α δ ODD转基因小鼠)。我们设计了
Cre-loxP介导的基底鳞状上皮中HIF-1a缺失,
可辨别的表型现在,我们测试HIF-1 α是否在
具有这些特定目的的多阶段上皮癌发生
1.确定HIF-1 α功能的获得或丧失对
Ha-ras启动了表皮癌的发生。1.1.检测HIF-1 α的增加是否
功能促进两阶段表皮化学致癌诱导
二甲基苯并蒽和肉豆蔻酸四佛波酯乙酸酯,
Kl 4-HIF-laz\ODD转基因小鼠。1.2. HIF-1 α两阶段检测的必要性
Cre-loxP介导的表皮HIF-1 α对小鼠的化学致癌作用
删除。2.0.确定多阶段HIF-1 α功能获得的生物学
人乳头瘤病毒16型早期转化诱发皮肤和宫颈癌的研究
地区2.1. HPV 16诱导的表皮细胞各阶段的试验改变
KI 4-HPV 16中HIF-1 α功能获得致癌作用:HIF-1 α或HIF-1 α
δ ODD双转基因小鼠。2.2.测试HIF-1 α之间的合作增益
雌激素在HPV 16诱发小鼠宫颈癌中的作用
HPV 16和HIF-1 α或HIF-1 α δ ODD转基因。3.0.试验生物学
HPV 16 E6-HIF-1 α共表达,并确定p53依赖或不依赖
E6与HIF-1 α的功能。3.1.创建Kl 4-E6 HIF-1 α或
K14-E6:H1 F-1 α δ ODD双转基因小鼠,并测定H1 F-1 α δ ODD双转基因小鼠中的改变。
皮肤和宫颈癌生物学。3.2.创建Kl 4-E6 HIF-1 α或
K14-E6:HIF-1 α δ ODD双转基因小鼠,并确定其基因表达的改变。
皮肤和宫颈癌生物学。我们拥有所有相关的
动物模型,使我们能够确定HIF-1 α在
由激活的癌基因或肿瘤失活介导的致癌作用
抑制基因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey Michael Arbeit其他文献
Jeffrey Michael Arbeit的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey Michael Arbeit', 18)}}的其他基金
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
肾癌生长和治疗中新生血管化的光声显微镜
- 批准号:
8293074 - 财政年份:2011
- 资助金额:
$ 24.23万 - 项目类别:
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
肾癌生长和治疗中新生血管化的光声显微镜
- 批准号:
8657908 - 财政年份:2011
- 资助金额:
$ 24.23万 - 项目类别:
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
肾癌生长和治疗中新生血管化的光声显微镜
- 批准号:
8139525 - 财政年份:2011
- 资助金额:
$ 24.23万 - 项目类别:
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
肾癌生长和治疗中新生血管化的光声显微镜
- 批准号:
8453472 - 财政年份:2011
- 资助金额:
$ 24.23万 - 项目类别:
Mammalian Target of Rapamycin in Prostate Carcinogenesis
雷帕霉素在前列腺癌发生中的哺乳动物靶点
- 批准号:
6941228 - 财政年份:2003
- 资助金额:
$ 24.23万 - 项目类别:
Mammalian Target of Rapamycin in Prostate Carcinogenesis
雷帕霉素在前列腺癌发生中的哺乳动物靶点
- 批准号:
6617272 - 财政年份:2003
- 资助金额:
$ 24.23万 - 项目类别:
Mammalian Target of Rapamycin in Prostate Carcinogenesis
雷帕霉素在前列腺癌发生中的哺乳动物靶点
- 批准号:
7121959 - 财政年份:2003
- 资助金额:
$ 24.23万 - 项目类别:
Mammalian Target of Rapamycin in Prostate Carcinogenesis
雷帕霉素在前列腺癌发生中的哺乳动物靶点
- 批准号:
7265289 - 财政年份:2003
- 资助金额:
$ 24.23万 - 项目类别:
Mammalian Target of Rapamycin in Prostate Carcinogenesis
雷帕霉素在前列腺癌发生中的哺乳动物靶点
- 批准号:
6801538 - 财政年份:2003
- 资助金额:
$ 24.23万 - 项目类别: